A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age
Фаза 1/2
Завершено
NCT05975099
| Заболевание | Lyme Disease |
|---|
| Фаза | Фаза 1/2 |
|---|
| Спонсор | ModernaTX, Inc. |
|---|
| Статус | Завершено |
|---|
| Участники | 807 участн. |
|---|
| Вмешательство | mRNA-1975, mRNA-1982 |
|---|
| Дата начала | 26.07.2023 |
|---|
| Дата завершения | 30.05.2025 |
|---|
| Публикация результатов | 30.07.2026 |
|---|
Кратко
The purpose of this study is to evaluate the safety and immunogenicity in parallel of heptavalent mRNA-1975 and monovalent mRNA-1982 against Lyme disease in healthy adult participants.
Number of Participants With Solicited Local and Systemic Adverse Reactions (ARs) Within 7 Days After Day 1 Injection
Up to 7 days after Day 1 injection · Participants
| mRNA-1975 Dose Level 1 | 70 Participants |
|---|
| mRNA-1975 Dose Level 2 | 80 Participants |
|---|
| mRNA-1975 Dose Level 3 | 82 Participants |
|---|
| mRNA-1975 Dose Level 4 | 91 Participants |
|---|
| mRNA-1982 Dose Level 1 | 64 Participants |
|---|
| mRNA-1982 Dose Level 2 | 77 Participants |
|---|
Number of Participants With Solicited Local and Systemic ARs Within 7 Days After Day 57 Injection
Up to 7 days after Day 57 injection · Participants
| mRNA-1975 Dose Level 1 | 79 Participants |
|---|
| mRNA-1975 Dose Level 2 | 80 Participants |
|---|
| mRNA-1975 Dose Level 3 | 90 Participants |
|---|
| mRNA-1975 Dose Level 4 | 96 Participants |
|---|
| mRNA-1982 Dose Level 1 | 70 Participants |
|---|
| mRNA-1982 Dose Level 2 | 82 Participants |
|---|
Number of Participants With Solicited Local and Systemic ARs Within 7 Days After Day 169 Injection
Up to 7 days after Day 169 injection · Participants
| mRNA-1975 Dose Level 1 | 81 Participants |
|---|
| mRNA-1975 Dose Level 2 | 87 Participants |
|---|
| mRNA-1975 Dose Level 3 | 81 Participants |
|---|
| mRNA-1975 Dose Level 4 | 92 Participants |
|---|
| mRNA-1982 Dose Level 1 | 76 Participants |
|---|
| mRNA-1982 Dose Level 2 | 82 Participants |
|---|
Открыть в BENITIONS
Открыть на ClinicalTrials.gov
Все исследования
Страница обобщает открытые данные ClinicalTrials.gov. Это не медицинская и не инвестиционная рекомендация. Обратитесь к врачу.